Multi-modal volumetric concept activation to explain detection and classification of metastatic prostate cancer on PSMA-PET/CT
Authors:
Rosa C. J. Kraaijveld,
Marielle E. P. Philippens,
Wietse S. C. Ep**a,
Ina M. Jürgenliemk-Schulz,
Kenneth G. A. Gilhuijs,
Petra S. Kroon,
Bas H. M. van der Velden
Abstract:
Explainable artificial intelligence (XAI) is increasingly used to analyze the behavior of neural networks. Concept activation uses human-interpretable concepts to explain neural network behavior. This study aimed at assessing the feasibility of regression concept activation to explain detection and classification of multi-modal volumetric data.
Proof-of-concept was demonstrated in metastatic pro…
▽ More
Explainable artificial intelligence (XAI) is increasingly used to analyze the behavior of neural networks. Concept activation uses human-interpretable concepts to explain neural network behavior. This study aimed at assessing the feasibility of regression concept activation to explain detection and classification of multi-modal volumetric data.
Proof-of-concept was demonstrated in metastatic prostate cancer patients imaged with positron emission tomography/computed tomography (PET/CT). Multi-modal volumetric concept activation was used to provide global and local explanations.
Sensitivity was 80% at 1.78 false positive per patient. Global explanations showed that detection focused on CT for anatomical location and on PET for its confidence in the detection. Local explanations showed promise to aid in distinguishing true positives from false positives. Hence, this study demonstrated feasibility to explain detection and classification of multi-modal volumetric data using regression concept activation.
△ Less
Submitted 4 August, 2022;
originally announced August 2022.
Automated causal inference in application to randomized controlled clinical trials
Authors:
Jiqing Wu,
Nanda Horeweg,
Marco de Bruyn,
Remi A. Nout,
Ina M. Jürgenliemk-Schulz,
Ludy C. H. W. Lutgens,
Jan J. Jobsen,
Elzbieta M. van der Steen-Banasik,
Hans W. Nijman,
Vincent T. H. B. M. Smit,
Tjalling Bosse,
Carien L. Creutzberg,
Viktor H. Koelzer
Abstract:
Randomized controlled trials (RCTs) are considered as the gold standard for testing causal hypotheses in the clinical domain. However, the investigation of prognostic variables of patient outcome in a hypothesized cause-effect route is not feasible using standard statistical methods. Here, we propose a new automated causal inference method (AutoCI) built upon the invariant causal prediction (ICP)…
▽ More
Randomized controlled trials (RCTs) are considered as the gold standard for testing causal hypotheses in the clinical domain. However, the investigation of prognostic variables of patient outcome in a hypothesized cause-effect route is not feasible using standard statistical methods. Here, we propose a new automated causal inference method (AutoCI) built upon the invariant causal prediction (ICP) framework for the causal re-interpretation of clinical trial data. Compared to existing methods, we show that the proposed AutoCI allows to efficiently determine the causal variables with a clear differentiation on two real-world RCTs of endometrial cancer patients with mature outcome and extensive clinicopathological and molecular data. This is achieved via suppressing the causal probability of non-causal variables by a wide margin. In ablation studies, we further demonstrate that the assignment of causal probabilities by AutoCI remain consistent in the presence of confounders. In conclusion, these results confirm the robustness and feasibility of AutoCI for future applications in real-world clinical analysis.
△ Less
Submitted 20 January, 2022; v1 submitted 15 January, 2022;
originally announced January 2022.
